May 06, 2021 09:17 PM IST
The comments come a day after the United States said it would support waiving intellectual property rights for COVID-19 vaccines in order to help speed an end to the pandemic, paving the way for what could be months of negotiations to hammer out a specific waiver plan.
- May 06, 2021 06:43 PM IST
- May 04, 2021 07:48 AM IST
Pfizer, which produces the COVID-19 vaccine with German partner BioNTech, reiterated that it would supply doses only through government contracts.
- May 03, 2021 12:19 PM IST
Last month, the pharmaceutical major had offered a not-for-profit price for its COVID-19 vaccine for the Indian government's immunisation programme.
- Apr 29, 2021 06:59 AM IST
"COVID-19 has infected over 148 million people and killed over three million globally, with hundreds of thousands of new cases and thousands of deaths being reported daily," the five senators wrote in identical letters to the CEOs of Pfizer, Moderna and Johnson & Johnson on Wednesday.
- Apr 21, 2021 08:44 PM IST
The city-based VAV Lifesciences is the only domestic firm in the COVID-19 vaccine supply chain with this crucial ingredient. It can thus can play a vital role in the global mRNA-based vaccine supply chain
- Apr 21, 2021 09:17 AM IST
An initial seven cases of the Indian variant were detected in Israel last week among people arriving from abroad and who have since undergo preliminary testing, the Health Ministry said.
- Apr 18, 2021 09:55 AM IST
While Moderna is 'not keen' to enter India because of its existing supply commitments, Pfizer's entry is conditional upon signing of an indemnity bond, a news report suggests.
- Apr 14, 2021 10:27 PM IST
- Apr 14, 2021 07:20 PM IST
The UK study also found that a critical component of the immune system known as T cells showed a more enhanced response in those who got the AstraZeneca/Oxford University vaccine than in those who got the Pfizer/BioNTech one.
- Apr 10, 2021 09:02 AM IST
New York-based Pfizer and BioNTech SE of Germany have asked the US Food and Drug Administration to expand the emergency use authorisation for their vaccine to include adolescents ages 12 through 15.
- Apr 08, 2021 04:45 PM IST
The move, after Europe’s drug regulator found a possible link between the Anglo-Swedish vaccine and rare blood clotting issues, is a huge hurdle for Australia's faltering inoculation effort, which relies heavily on the AstraZeneca vaccine.
- Apr 06, 2021 09:42 PM IST
If NDV-HXP-S proves safe and effective, flu vaccine manufacturers could potentially produce well over a billion doses of it a year. Low- and middle-income countries currently struggling to obtain vaccines from wealthier countries may be able to make NDV-HXP-S for themselves or acquire it at low cost from neighbors.
- Apr 06, 2021 08:46 AM IST
After the onset of the lockdown, we at Stockal saw a 300% growth in Indian investors on the platform. In terms of volumes, Stockal processed $400 million worth of transactions during this financial year, says Srivastava.
- Apr 02, 2021 09:20 AM IST
Pfizer's CEO Albert Bourla said the updated result positions the drugmakers to submit for full US regulatory approval for the vaccine against COVID-19.
- Mar 31, 2021 05:33 PM IST
The absolute efficacy of the vaccine was recorded in the third phase of clinical trials on the minor volunteers.
- Mar 26, 2021 07:44 AM IST
The Pfizer-BioNTech vaccine against COVID-19 was authorized by US regulators in late December for people age 16 and older.
- Mar 24, 2021 07:58 AM IST
The statements from Hong Kong and Macau did not give any details on how the packaging was defective.
- Mar 10, 2021 05:24 PM IST
The US company pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its request to skip a small local safety trial. That has kept its vaccine, developed with Germany's BioNTech SE, out of one of the world's biggest drug markets.
- Mar 09, 2021 05:04 PM IST
Pfizer-BioNTech vaccine, however, showed a “robust but lower” activity against the South Africa variant.
- Mar 07, 2021 05:45 PM IST
Letters from the National Health Service (NHS) to around 850,000 people in that age group were issued this weekend with a further 850,000 due to arrive by Monday.
- Mar 07, 2021 04:55 PM IST
The easing of restrictions comes after months of government-imposed shutdowns and less than three weeks before the countrys fourth parliamentary elections in two years.
- Mar 07, 2021 07:58 AM IST
"It is essential that these vaccines be used as authorized by FDA in order to prevent Covid-19 and related hospitalizations and death," Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, told the Journal.
- Mar 02, 2021 07:49 PM IST
Seth Berkley, CEO of the GAVI alliance that co-leads the COVAX multilateral vaccine facility with the World Health Organization (WHO), told journalists the requirements were partly related to indemnification issues.
- Mar 02, 2021 09:57 AM IST
Fauci said that delaying a second dose to inoculate more Americans creates risks, the newspaper on Monday.